Quantcast

Posts related to ‘prostate cancer’

biotech

Dendreon Shows Poor Provenge Sales, Implosion Risk Rising

Posted: May 9, 2013 at 10:25 am

Dendreon Corp. (NASDAQ: DNDN) just cannot catch a break. Despite having what was supposed to be one of the best late-stage prostate treatments in Provenge, sales just are not coming ...
Read Full Story »

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Posted: May 10, 2012 at 12:02 pm

It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  ...
Read Full Story »

What To Expect As Warren Buffett Battles Prostate Cancer (BRK-A, BRK-B, AXP, KO, KFT, PG, WFC)

Posted: April 17, 2012 at 5:46 pm

Warren Buffett is supposed to be invincible.  Unfortunately the world is finding out that this is not the case.  A disclosure letter came from Mr. Buffett and Berkshire Hathaway Inc. ...
Read Full Story »